WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998003162) MEDICINAL COMPOSITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/003162    International Application No.:    PCT/JP1997/002448
Publication Date: 29.01.1998 International Filing Date: 15.07.1997
Chapter 2 Demand Filed:    22.01.1998    
IPC:
A61K 31/135 (2006.01), A61K 47/48 (2006.01)
Applicants: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. [JP/JP]; 6-9, Hirano-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541 (JP) (For All Designated States Except US).
SAKAI, Atsushi [JP/JP]; (JP) (For US Only).
KUMA, Rumiko [JP/JP]; (JP) (For US Only).
FUJII, Tsuneo [JP/JP]; (JP) (For US Only).
MISHINA, Tadashi [JP/JP]; (JP) (For US Only).
CHIBA, Kenji [JP/JP]; (JP) (For US Only)
Inventors: SAKAI, Atsushi; (JP).
KUMA, Rumiko; (JP).
FUJII, Tsuneo; (JP).
MISHINA, Tadashi; (JP).
CHIBA, Kenji; (JP)
Agent: AOYAMA, Tamotsu; Aoyama & Partners, IMP Building, 3-7, Shiromi 1-chome, Chuo-ku, Osaka-shi, Osaka 540 (JP)
Priority Data:
8/189380 18.07.1996 JP
Title (EN) MEDICINAL COMPOSITIONS
(FR) COMPOSITIONS MEDICINALES
Abstract: front page image
(EN)Medicinal compositions which can be processed into solutions and are useful in inhibiting rejection reactions against the transplantation of organs or bone marrow, in the maintenance immunotherapy therefor or in treating autoimmune diseases, characterized by containing 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol or pharmaceutically acceptable acid-addition salts thereof and cyclodextrins optionally together with saccharides, if required.
(FR)Compositions médicinales pouvant être traitées sous forme de solutions et destinées à être utilisées pour inhiber les réactions de rejet dans le cadre de la transplantation d'organes ou de moelle osseuse, dans l'immunothérapie d'entretien à cet effet ou pour le traitement de maladies auto-immunes, caractérisées en ce qu'elles contiennent du 2-amino-2-[2-(4-octylphényl)éthyl]propane-1,3-diol ou leurs sels d'addition d'acide pharmaceutiquement acceptables et des cyclodextrines, éventuellement, le cas échéant, avec des saccharides.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, HU, IL, IS, JP, KE, KG, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)